NCT00387608View on ClinicalTrials.gov

ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2009

Conditions
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

veliparib

OTHER

pharmacological study

PROCEDURE

biopsy

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00387608 - ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | Biotech Hunter | Biotech Hunter